
Keywords: Breast cancer; Tumor microenvironment; Extracellular matrix; Tumor stroma component; ECM-related signatures; ER; estrogen receptor; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; FEC; 5-fluorouracil+doxorubicin+cyclophosphamide; NKI; Neth